Hennion & Walsh Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Hennion & Walsh Asset Management's BIIB Position: Q2 2025 in Review
Hennion & Walsh Asset Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 1,891 shares — an estimated $259K sold.
Hennion & Walsh Asset Management first reported a position in BIIB in Q1 2021 and held it in 15 quarters. The position peaked at $1.83M in Q4 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- Hennion & Walsh Asset Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
- Hennion & Walsh Asset Management sold 1,891 Biogen shares in Q2 2025, an estimated $259K.
- Hennion & Walsh Asset Management first reported a position in Biogen in Q1 2021 and held it in 15 quarters.
- Hennion & Walsh Asset Management's Biogen position peaked at $1.83M in Q4 2023.
- 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.